Teva Pharmaceuticals USA, Inc: Clonidine Transdermal System, USP, 0.3 mg/day,
Recall reason: CGMP Deviations: use of an unapproved raw material. Recalled by Teva Pharmaceuticals USA, Inc. Distribution: Within U.S. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot: 100053892, Exp.: 04/2026; 100057899, Exp.: 05/2026; 100062704, Exp.: 02/2027.. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report